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Dear Editor, 
The surgical management of prostate cancer has been shown to be determined by the 
anatomical location of the tumour and its associated intricate relationship to the 
neurovascular bundle and the prostatic capsule. Studies have shown an improvement in 
decision making about preservation or resection of neurovascular bundles during robotic 
assisted prostatectomy (RARP) [1,2] during which the surgeon lacks the tactile feedback of 
conventional open surgery. In T3 disease, around 35% positive margin rates have been 
reported [3] irrespective of the open or minimally invasive approach. In this context, 
improvement in tactile appreciation of the size, number and location of the tumour(s) 
during RARP may prove useful. Early reports of preoperative 3D printing technology in 
urological surgery have focused on proof of concept, face and content validity [4,5]. We 
report an IDEAL phase 2a study [6] of the use of patient specific 3D printing in RARP. 
 
10 patients with localised T3 prostate cancer either clinically or on pre-biopsy multi-
parametric magnetic resonance imaging (MRI), subsequently treated with RARP, were 
included in this prospective pilot study after ethics approval, patient consent and discussion 
at the regional multidisciplinary team meeting (MDT). 
 
Patient-specific geometries were segmented from MRI data. The 2D, axial, T2 images were 
used. To account for the relatively coarse resolution (typically 3 mm) of these scans, all 
image segmentation was also informed by biopsy result and at least one of coronal and 
sagittal T2 acquisitions and diffusion weighted imaging. Manual segmentation was 
performed using Mimics Medical v.18.0 (Materialise, Leuven, Belgium) with the multi slice 
editing tool. Boolean subtraction of the tumour from the prostate geometry was completed 
using 3-Matic Medical v.10.0 (Materialise, Leuven, Belgium) and ensured two isolated 
components,that were subsequently exported in standard triangulation language (STL) file 
format. Patient-specific models were printed in house using multimaterial polyjet printing 
technology (Objet500 Connex1, Objet-Stratasys, Rehovot, Israel). Materials were assigned 
such that the tumour could be visualised and palpated as an opaque structure within a 
transparent prostate gland (VeroClear FullCure810, UK). 
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All RARPs were performed by a single surgeon who inspected the 3D model prior to surgery 
and took it into the operating room during the procedure. This allowed tactile interaction 
with the model and incremental nerve spare or wider excision of the neurovascular bundles 
were performed around the palpable tumours. For anterior tumours the fat in front of the 
prostate was sent for histology. The models were also shown to the patients as part of the 
informed consent process prior to the procedure and given to the patients after surgery. 
The final excised prostates were sent for histological examination.  
 
The mean patient age was 58y (54-68) and mean PSA was 6.2 (3.8 - 14.9). Bilateral nerve 
sparing was achieved in 2 patients with anterior tumours, unilateral nerve spare and wider 
excision in 5 patients and unilateral nerve spare and contralateral incremental nerve spare 
in the remaining 3 patients. There were no intraoperative complications and all patients had 
an unremarkable post-operative recovery. 
 
The Gleason score was 3+4 (Grade Group 2) in 4 patients, 4+3 in (Grade Group 3) in 3 
patients, 4+4 (Grade Group 4) in 2 patients and Gleason 4+5 (Grade Group 5) in 1 patient. 
The final pathological stage was pT2 in 3 (down-staged), pT3a in 6 and pT3b in 1 patient. 
One patient (10%) had a positive margin of 1 mm at the apex. There were no positive lymph 
nodes and the anterior fat biopsies were clear. All patients have completed at least one-
year follow-up with the pT3b patient opting for adjuvant radiotherapy. There have been no 
biochemical recurrences thus far. Continence (no pads) was immediate in 40%, 70% at 3 
months, 80% at 6 months and 100% at 12 months. With penile rehabilitation, of 7 patients 
with pre-operative SHIM scores >21, 4 achieved erections strong enough for intercourse at 
24 months, which included the two patients with anterior tumours who had bilateral nerve 
sparing. All patients found “personalised” counselling using their 3D printed prostates useful 
although this has not been compared to standard of care where a 3D print was not used. 
 
3D printing is a cutting-edge topic and we chose to explore its potential role in RARP, 
adopting the IDEAL framework as a basis for this implementation, progressing from phase 1 
(idea) to phase 2a (development) within this small cohort of patients. The models do not 
however replicate normal tissue elasticity and add extra cost to the procedure (~£250). A 
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multi-centre randomised controlled trial - TIGERS (Touch and Image Guided Robotic 
Surgery) is being planned with positive margins as the primary outcome. 
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Figure 1: 3D print with post-operative prostate gland showing anatomical geometrical 
correlation between the anterior tumour on the model (blue) and the tumour localised on the 
prostate (blue outline). The tumour was T3 on MRI and very close to the sphincter 
 
 
 
 
 
 
